1. ALLA AKTIER
  2. NYHETER
  3. PROLIGHT DIAGNOSTICS

Prolight Diagnostics

Nyheter Prolight Diagnostics Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

BioStock publishes article after Prolight signed supply agreement with BRAINBox valued at USD 3.9 million

BioStock publishes article after Prolight Diagnostics signed supply agreement with BRAINBox valued at USD 3.9 million during the first year, with comments from Prolight.

Read the full article here: https://biostock.se/en/2026/09/prolight-comments-on-usd-3-9m-brainbox-deal/ 

For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com

About Us
Prolight Diagnostics develops Psyros®, a groundbreaking Point-of-Care platform for highly sensitive biomarker diagnostics. By delivering reliable test results in ten minutes or less, Psyros has the potential to revolutionize clinical workflows, improve patient outcomes, and reduce healthcare costs. The platform is initially being developed for areas with significant unmet medical needs such as cardiovascular and neurological conditions and possesses broad potential for a wide range of clinical applications.
 
The company’s share is traded on the NGM Growth Market marketplace, under the ticker PRLD.

Attachments
BioStock publishes article after Prolight signed supply agreement with BRAINBox valued at USD 3.9 million

Datum 2026-09-08, kl 08:15
Källa MFN
Bifogade filer
BioStock publishes article after Prolight signed supply agreement with BRAINBox valued at USD 3.9 million